ArticleMolecular medicine reports2020

Shikonin inhibits CEBPD downregulation in IL‑17‑treated HaCaT cells and in an imiquimod‑induced psoriasis model.

Xiao-Ou Lan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.